Q4 2015 13F Holders as of 12/31/2015
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
93.1M
-
Number of holders
-
226
-
Total 13F shares, excl. options
-
89.6M
-
Shares change
-
-1.65M
-
Total reported value, excl. options
-
$3.87B
-
Value change
-
-$59.1M
-
Put/Call ratio
-
1.5
-
Number of buys
-
94
-
Number of sells
-
-121
-
Price
-
$43.16
Significant Holders of MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) as of Q4 2015
274 filings reported holding MYGN - MYRIAD GENETICS INC - Common Stock, par value $0.01 per share as of Q4 2015.
MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) has 226 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 89.6M shares
of 93.1M outstanding shares and own 96.29% of the company stock.
Largest 10 shareholders include BAILLIE GIFFORD & CO (11.3M shares), Capital Research Global Investors (8.87M shares), Capital World Investors (6.66M shares), SCOPIA CAPITAL MANAGEMENT LP (6.46M shares), VANGUARD GROUP INC (4.85M shares), IRIDIAN ASSET MANAGEMENT LLC/CT (3.89M shares), FMR LLC (2.87M shares), BlackRock Fund Advisors (2.66M shares), FIRST TRUST ADVISORS LP (2.64M shares), and D. E. Shaw & Co., Inc. (2.48M shares).
This table shows the top 226 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.